Group One Trading
BIVV

Group One Trading’s Bioverativ Inc. Common Stock BIVV Stock Holding History

Group One Trading’s Portfolio BIVV Stock Details BIVV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-27,999
Closed -$1.51M – 5676
2017
Q4 		$1.51M Sell
27,999
-3,851
-12% -$211K 0.01% 1378
2017
Q3 		$1.82M Buy
31,850
+14,112
+80% +$827K 0.02% 1112
2017
Q2 		$1.07M Sell
17,738
-6,545
-27% -$373K 0.01% 1408
2017
Q1 		$1.32M Buy
+24,283
New +$1.2M 0.02% 1139

Other funds holding BIVV

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
ACS
Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

Group One Trading's BIVV Position: Q1 2018 in Review

Group One Trading sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 27,999 shares — an estimated $1.51M sold.

Group One Trading first reported a position in BIVV in Q1 2017 and held it in 4 quarters. The position peaked at $1.82M in Q3 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

  • Group One Trading reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
  • Group One Trading sold 27,999 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $1.51M.
  • Group One Trading first reported a position in Bioverativ Inc. Common Stock in Q1 2017 and held it in 4 quarters.
  • Group One Trading's Bioverativ Inc. Common Stock position peaked at $1.82M in Q3 2017.
  • 2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on Group One Trading's 13F filing for Q1 2018, filed 11 May 2018.